Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Retinoic acid receptor beta (RARβ), encoded by the RARB gene, is a nuclear receptor and transcription factor that belongs to the thyroid-steroid hormone receptor superfamily. It plays a crucial role in embryonic development, cell growth, differentiation, and homeostasis. As a tumor suppressor, its deletion or silencing is associated with various cancers. RARβ forms functional heterodimers with retinoid X receptors (RXRs) and binds to retinoic acid response elements (RAREs) to regulate gene expression. The unique structure of its ligand-binding domain allows for the development of isoform-selective ligands.
Ligand binding to RARβ leads to heterodimerization with RXR, binding to RAREs on DNA, and regulation of gene transcription. Selective agonists can induce tumor-specific apoptosis.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Retinoic acid receptor beta (RARβ).